Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism PDE3A modulators(phosphodiesterase 3A modulators), SLFN12 modulators(schlafen family member 12 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myelodysplastic Syndromes | Discovery | - | 29 Sep 2022 | |
Myelodysplastic Syndromes | Discovery | - | 29 Sep 2022 | |
Neoplasms | Discovery | - | 29 Sep 2022 | |
Neoplasms | Discovery | - | 29 Sep 2022 |